BEAM - Beam Therapeutics Inc.
25.52
-1.920 -7.524%
Share volume: 2,087,868
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$27.44
-1.92
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-05-2024 | 02-25-2025 | 05-06-2025 | 11-04-2025 | 02-24-2026 | |
| Assets | ||||||||
| Total Assets | 1.360 B | 1.261 B | 1.171 B | 1.104 B | 1.467 B | 1.311 B | 1.481 B | |
| Current Assets | 1.122 B | 1.029 B | 945.534 M | 878.149 M | 1.248 B | 1.099 B | 1.269 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 806.706 M | 715.402 M | 695.554 M | 568.773 M | 692.045 M | 807.010 M | 950.266 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 287.848 M | 292.763 M | 230.203 M | 281.967 M | 527.907 M | 267.960 M | 294.944 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 120.922 M | 117.470 M | 113.502 M | 111.412 M | 109.569 M | 108.290 M | 104.500 M | |
| Other Assets | 117.164 M | 114.356 M | 112.331 M | 114.263 M | 109.737 M | 104.244 M | 107.989 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 1.360 B | 1.261 B | 1.171 B | 1.104 B | 1.467 B | 1.311 B | 1.481 B | |
| Total liabilities | 446.306 M | 407.172 M | 380.050 M | 370.279 M | 343.784 M | 345.079 M | 242.819 M | |
| Total current liabilities | 187.219 M | 177.333 M | 166.244 M | 182.066 M | 141.546 M | 182.559 M | 96.935 M | |
| Accounts Payable | 2.790 M | 4.429 M | 3.812 M | 3.871 M | 7.699 M | 9.545 M | 10.231 M | |
| Other liabilities | 159.514 M | 154.352 M | 155.990 M | 154.995 M | 152.835 M | 152.360 M | 145.884 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 159.514 M | 154.352 M | 155.990 M | 154.995 M | 152.835 M | 152.360 M | 145.884 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 913.490 M | 854.094 M | 791.317 M | 733.545 M | 1.123 B | 966.002 M | 1.238 B | |
| Common stock | 2.203 B | 2.235 B | 2.266 B | 2.299 B | 2.799 B | 2.856 B | 2.878 B | |
| Retained earnings | -1.289 B | -1.380 B | -1.476 B | -1.567 B | -1.676 B | -1.891 B | -1.641 B |